Results 21 to 30 of about 282,881 (309)
WHO estimates show that 296 million people were living with chronic hepatitis B infection in 2019 with 1.5 million new infections occurring every year and approximately 290 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular ...
C. Roopa +3 more
doaj +1 more source
Background and aims: Hepatitis C virus (HCV) represents a major worldwide public health problem requiring global action for the diagnosis, treatment and prevention of this infection.
Sara Salvetti +2 more
doaj +1 more source
Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system [PDF]
Extrahepatic disease manifestations are common in chronic hepatitis C virus (HCV) infection. The mechanism of HCV-related lymphoproliferative disorders is not fully understood.
Alter, Harvey J. +7 more
core +1 more source
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge [PDF]
End-stage liver disease caused by hepatitis C virus (HCV) infection is a major indication for liver transplantation. However, immediately after transplantation the liver graft of viremic patients universally becomes infected by circulating virus ...
Baumert, Thomas F. +12 more
core +3 more sources
Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the innate cellular response [PDF]
Hepatitis C virus (HCV) is a single-stranded positive-sense RNA hepatotropic virus. Despite cellular defenses, HCV is able to replicate in hepatocytes and to establish a chronic infection that could lead to severe complications and hepatocellular ...
Cesarec, Mia +5 more
core +1 more source
IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus
INTRODUCTION: IgG subclasses involved in the immune response to hepatitis C virus (HCV) antigens have been rarely studied. We investigated the immune response mediated by IgG1 and IgG4 antibodies against the recombinant core and NS3 antigens in patients
Vanessa Costa dos Santos +4 more
doaj +1 more source
High prevalence of anti-hepatitis e virus antibodies among blood donors in central Italy, february to march 2014 [PDF]
Prevalence of anti-hepatitis E virus (HEV) antibodies is highly variable in developed countries, which seems partly due to differences in assay sensitivity.
Bruni, R. +13 more
core +1 more source
BACKGROUND: World health organization estimated that approximately 170 million people are infected with Hepatitis C virus with about 130 million being carriers, three to four million persons are newly infected in each year and more than 350,000 people ...
E L Kotingo +5 more
doaj +1 more source
Hepatitis B/C virus co-infection in Iran: A seroepidemiological study [PDF]
Background/aims: As hepatitis B and C virus have the same transmission routes, dual infection may occur. The aim of this study was to determine the seroprevalence of HCV in HBsAg-positive subjects.
Abdolahi, N. +13 more
core
Seroprevalence of Hepatitis E among Boston Area Travelers, 2009-2010 [PDF]
We determined the prevalence of IgG antibodies to hepatitis E virus (anti-HEV IgG) among travelers attending Boston-area travel health clinics from 2009 to 2010.
Barbre, Kira A. +5 more
core +1 more source

